Addendum: Influenza Vaccine 2006-2007
Superseded by The Medical Letter "Influenza Vaccine for 2011-2012" - Issue 1375, October 17, 2011
Since the publication of our article on influenza vaccine (October 9, 2006), a fourth inactivated vaccine (FluLaval - GlaxoSmithKline) has been approved by the FDA for use in people ≥18 years old. It is sold in 5-mL multi-dose vials. Each 0.5-mL intramuscular dose contains 25 mcg of mercury....
Since the publication of our article on influenza vaccine (October 9, 2006), a fourth inactivated vaccine (FluLaval - GlaxoSmithKline) has been approved by the FDA for use in people ≥18 years old. It is sold in 5-mL multi-dose vials. Each 0.5-mL intramuscular dose contains 25 mcg of mercury....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Addendum: Influenza Vaccine 2006-2007
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1246
Article Code: 1246c
Date: October 23, 2006
Volume: 48
Page: 85
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1246
Article Code: 1246c
Date: October 23, 2006
Volume: 48
Page: 85
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)